FDA Official Vinay Prasad To Exit As Trump Team Weighs Replacement

marked by high-profile disputes over vaccine approvals, drug policy and the agency’s broader regulatory direction.

He drew criticism from some inside the agency for overruling

Career scientists on certain vaccine decisions and for taking action against a biotech company linked to the deaths of two teenagers, The New York Times reported. Prasad, an oncologist,continue reading …